(MedPage Today) — A new warning will be added to the label of certain attention deficit-hyperactivity disorder (ADHD) medications over the risk of “significant” weight-loss in young children, the FDA said.
Labels of all extended-release stimulants…
Source link : https://www.medpagetoday.com/pediatrics/adhd-add/116370
Author :
Publish date : 2025-07-02 19:00:00
Copyright for syndicated content belongs to the linked Source.
